Département de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier Universitaire de Lille, Lille, France.
Université de Lille, Centre Hospitalier Universitaire de Lille, Equipe d'Accueil A2694-Santé publique: épidémiologie et qualité des soins, Lille, France.
PLoS One. 2018 Jun 29;13(6):e0198726. doi: 10.1371/journal.pone.0198726. eCollection 2018.
The use of therapeutic body wraps (TBW) has been reported in small series or case reports, but has become controversial.
This is a feasibility, multicentre, randomized, controlled, open-label trial with blinded outcome assessment (PROBE design).
Children with autism and severe-injurious behaviours (SIB) were enrolled from 13 specialized clinics.
Dry-sheet TBW (DRY group) vs. wet-sheet TBW (WET group).
3-month change in the Aberrant Behaviour Checklist irritability score (ABC-irritability) within per-protocol (PP) sample.
From January 2008 to January 2015, we recruited 48 children (age range: 5.9 to 9.9 years, 78.1% male). Seven patients (4 in the DRY group, 3 in the WET group) were dropped from the study early and were excluded from PP analysis. At endpoint, ABC-irritability significantly improved in both groups (means (standard deviation) = -11.15 (8.05) in the DRY group and -10.57 (9.29) in the WET group), as did the other ABC scores and the Children Autism Rating scale score. However, there was no significant difference between groups. All but 5 patients were rated as much or very much improved. A repeated-measures analysis confirmed the significant improvement in ABC-irritability scores according to time (p < .0001), with no significant difference between the two groups (group effect: p = .55; interaction time x group: p = .27). Pooling both groups together, the mean 3-month change from baseline in ABC-irritability score was -10.90 (effect size = 1.59, p < .0001).
We found that feasibility was overall satisfactory with a slow recruitment rate and a rather good attrition rate. TBW was a safe complementary therapy in this population. There was no difference between wet and dry TBW at 3 months, and ABC-irritability significantly decreased with both wet and dry sheet TBW. To assess whether TBW may constitute an alternative to medication or behavioural intervention for treating SIB in ASD patients, a larger randomized comparative trial (e.g. TBW vs. antipsychotics) is warranted.
ClinicalTrials.gov NCT03164746.
治疗性身体包裹(TBW)的使用已在小系列或病例报告中报道,但已引起争议。
这是一项可行性、多中心、随机、对照、开放标签、结局评估盲法(PROBE 设计)试验。
从 13 个专门诊所招募自闭症和严重伤害行为(SIB)的儿童。
干片 TBW(DRY 组)与湿片 TBW(WET 组)。
在符合方案(PP)样本中,3 个月时异常行为检查表烦躁评分(ABC-irritability)的变化。
从 2008 年 1 月至 2015 年 1 月,我们招募了 48 名儿童(年龄范围:5.9 至 9.9 岁,78.1%为男性)。7 名患者(DRY 组 4 名,WET 组 3 名)提前退出研究并被排除在 PP 分析之外。在终点时,两组的 ABC-irritability 均显著改善(DRY 组平均值(标准差)为-11.15(8.05),WET 组为-10.57(9.29)),其他 ABC 评分和儿童自闭症评定量表评分也是如此。然而,两组之间没有显著差异。除 5 名患者外,其余患者均被评为明显或非常明显改善。重复测量分析证实,根据时间 ABC-irritability 评分显著改善(p<0.0001),两组间无显著差异(组效应:p=0.55;时间 x 组交互作用:p=0.27)。将两组合并,ABC-irritability 评分从基线的 3 个月平均变化为-10.90(效应量=1.59,p<0.0001)。
我们发现,尽管招募速度较慢且脱落率较高,但总体而言,可行性令人满意。TBW 是该人群中一种安全的补充治疗方法。在 3 个月时,湿 TBW 和干 TBW 之间没有差异,湿和干 TBW 均显著降低 ABC-irritability。为了评估 TBW 是否可以替代 ASD 患者的药物治疗或行为干预来治疗 SIB,需要进行更大的随机对照试验(例如,TBW 与抗精神病药)。
ClinicalTrials.gov NCT03164746。